Supplemental Financial Information - Schedule of Foreign Exchange and Other Income/(Expense) (Details) - USD ($) $ in Thousands |
3 Months Ended | |
|---|---|---|
Mar. 31, 2026 |
Mar. 31, 2025 |
|
| Derivative Instruments, Gain (Loss) [Line Items] | ||
| Interest income | $ 3,552 | $ 6,443 |
| Impairment of investment | (1,132) | 0 |
| FX fluctuations | (589) | (610) |
| Investment revaluation - Ceribell, Inc. | 0 | (2,614) |
| Other | 98 | (73) |
| Foreign exchange and other income/(expense) | (5,695) | 11,416 |
| 2029 Embedded Derivative | 2029 Notes | ||
| Derivative Instruments, Gain (Loss) [Line Items] | ||
| Fair value adjustment | (9,350) | 14,593 |
| 2029 Embedded Derivative | 2025 Notes | ||
| Derivative Instruments, Gain (Loss) [Line Items] | ||
| Fair value adjustment | 0 | 2,041 |
| 2029 Capped Calls | 2029 Notes | ||
| Derivative Instruments, Gain (Loss) [Line Items] | ||
| Fair value adjustment | 1,726 | (6,545) |
| 2029 Capped Calls | 2025 Notes | ||
| Derivative Instruments, Gain (Loss) [Line Items] | ||
| Fair value adjustment | $ 0 | $ (1,819) |
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of impairment loss on investment in equity security without readily determinable fair value. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, before tax, of realized and unrealized gain (loss) from foreign currency transaction. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Aggregate net gain (loss) on all derivative instruments recognized in earnings during the period, before tax effects. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of realized and unrealized gain (loss) on investment. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of income (expense) related to nonoperating activities, classified as other. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|